Dr. Douglas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
777 Bannock St
Davis 3 South, MC 4000
Denver, CO 80204Phone+1 303-602-5013
Summary
- Dr. Ivor Douglas is an academic critical care specialist and pulmonologist in Denver, CO and is affiliated with multiple hospitals in the area, including Denver Health, University of Colorado Hospital, and UCHealth Poudre Valley Hospital. He received his medical degree from University of the Witwatersrand and has been in practice 27 years. He is experienced in sepsis, critical care medicine, systemic inflammatory response syndrome, cardiopulmonary resuscitation, and health policy. Dr. Douglas has been recognized for 12 years as a 5280 Best Docs critical care physician
Clinical Expertise
- Sepsis, Systemic inflammatory response syndrome, Adult respiratory distress syndrome, Critical care medicine, Health policy, Microbiological Techniques, Healthcare delivery, Delirium, Withdrawal, Cardiopulmonary resuscitation, Acute lung injury, Pneumonia, Respiratory insufficiency, Severity of illness index
Education & Training
- University of ChicagoFellowship, Pulmonary Disease and Critical Care Medicine, 1997 - 2000
- University of the WitwatersrandClass of 1990
Certifications & Licensure
- CO State Medical License 2002 - 2025
- NY State Medical License 1999 - 2020
- IL State Medical License 1995 - 1999
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
- Royal College of Physicians (UK)Fellow of the Royal College of Physicians (FRCP, UK)
Awards, Honors, & Recognition
- 5280 Magazine, Top Doc Critical Care 5280, 2008-2019, 2023-2024
- Clinician of the year award Denver Health Medical Center, 2016
Clinical Trials
- Pilot Study of Haloperidol to Treat Critical Illness Delirium Start of enrollment: 2005 Dec 01
- Study to Determine Quicker Methods of Diagnosing Pneumonia Caused by a Breathing Machine in Critically Ill Patients Start of enrollment: 2009 Jul 01
- The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study Start of enrollment: 2011 Dec 14
- Join now to see all
Publications & Presentations
PubMed
- 883 citationsDrotrecogin alfa (activated) in adults with septic shockV. Marco Ranieri, B. Taylor Thompson, Philip S. Barie, Jean-François Dhainaut, Ivor S. Douglas
The New England Journal of Medicine. 2012-05-30 - 474 citationsEarly Neuromuscular Blockade in the Acute Respiratory Distress SyndromeLung
The New England Journal of Medicine. 2019-05-10 - 5443 citationsSurviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012R. Phillip Dellinger, Mitchell M. Levy, Andrew Rhodes, Djillali Annane, Herwig Gerlach
Intensive Care Medicine. 2013-01-30
Journal Articles
- Tocilizumab in Hospitalized Patients with Severe Covid-19 PneumoniaIvan O Rosas, Ronaldo C Go, Ivor S Douglas, Larry Tsai, Atul Malhotra, The New England Journal of Medicine
Press Mentions
- COVID-19 Modeling Team: Colorado Should Increase Mitigation StrategiesNovember 11th, 2021
- Colorado COVID Hospitalizations Highest Since MayAugust 23rd, 2021
- For the First Time in a Long Time, Denver ERs Don't Feel Overwhelmed by COVIDMay 29th, 2021
- Join now to see all
Grant Support
- Impact of SARS CoV2 on post-hospital recovery of carbohydrate and muscle metabolism: role of endothelial injuryNIH2021–2024
- Prediction of Functional Outcomes from Chronic Critical Illness (CCI)NIH2016–2021
- Angiogenesis In Hyperoxic Lung FibrosisNational Heart, Lung, And Blood Institute2003–2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: